We are live on ! Find out more
LIXTW

Lixte Biotechnology Warrants
LIXTW

Delisted

LIXTW was delisted on the 26th of November, 2025.

Back to rankings

2 hedge funds and large institutions have $4.27K invested in Lixte Biotechnology Warrants in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.13% more ownership

Funds ownership: 0.71% → 3.84% (+3.1%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

33% less funds holding

Funds holding: 3 → 2 (-1)

55% less capital invested

Capital invested by funds: $9.42K → $4.27K (-$5.15K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$7

Top Sellers

Rank Fund Capital Flow
1
EFG
Ethos Financial Group
Pennsylvania
-$3.63K
2
WAM
Warberg Asset Management
Illinois
-$854
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Warberg Asset Management
Illinois
$2.58K -$854 -12,306 -23%
CS
2
Clear Street
New York
$1.69K +$7 +100 +0.4%
EFG
3
Ethos Financial Group
Pennsylvania
– -$3.63K -42,105 Closed

LIXTW Hedge Fund Activity: Q3 2023 in Review

2 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Lixte Biotechnology Warrants (LIXTW) for Q3 2023, worth a combined $4.27K — down 55% from $9.42K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of LIXTW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Clear Street, adding an estimated $7. The largest seller was Ethos Financial Group, exiting entirely with an estimated $3.63K sold.

  • 2 institutional investors held Lixte Biotechnology Warrants (LIXTW) as of Q3 2023, down from 3 in Q2 2023.
  • Funds reported $4.27K of Lixte Biotechnology Warrants stock for Q3 2023, down 55% quarter-over-quarter.
  • 0 funds opened new Lixte Biotechnology Warrants positions in Q3 2023 and 1 closed out, a net change of -1 holder.
  • The largest Lixte Biotechnology Warrants buyer in Q3 2023 was Clear Street, an estimated $7 added.
  • The largest Lixte Biotechnology Warrants seller in Q3 2023 was Ethos Financial Group, an estimated $3.63K sold.

Based on aggregated 13F filings for Q3 2023.